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Objective: To examine the significance of VZV-IgG (IgG) enzyme immunoassay (EIA) and 
the determination of peripheral blood lymphocyte counts in the diagnosis of ophthalmic zoster 
sine herpete (ophthalmic ZSH).
Method: Clinical case-control study with a sample of 65 patients with ophthalmic ZSH (16 males 
and 49 females; mean age 56 ± 18 years) in whom pressure elicited pain in tender points of Valleix 
(tender points of sites at which the trigeminal nerve appears subcutaneously). A total of 41 healthy 
controls (17 males and 24 females, mean age 48 ± 21 years) were also recruited. In each group, IgG 
and lymphocyte count were determined upon receiving the consent of patients. Multiple logistic 
regression analysis was used to evaluate the factors associated with diagnosis of ophthalmic ZSH. 
Odds ratios and 95% confidence intervals (CI) were determined for each variable.
Results: Lymphocyte count in the patients with ophthalmic ZSH was significantly low, though 
there were no significant differences in age, gender, and IgG between the two groups. Multiple 
logistic regression analysis revealed that lymphocytes pose a significant prognostic factor, and 
in case of 1,800 lymphocytes/µl or more, the odds ratio to less than1,800 lymphocytes/µl was 
0.29 (95% CI: 0.12–0.72).
Conclusion: Patients with orbital pain should be suspected as having ophthalmic ZSH as this 
allows for the determination of lymphocyte counts after tender points were confirmed. The 
swift diagnosis of ophthalmic ZSH and the administration of antiviral drugs from an early stage 
improve the subjective symptoms of the patient and is regarded as necessary to reduce the risk 
of severe complications.
Keywords: ophthalmic ZSH, lymphocytes count, VZV-IgG, tender points of Valleix, orbital 
pain, antiviral drugs
Zoster sine herpete (ZSH) has been defined as pain in a dermatomal distribution 
without the rash of cutaneous zoster.1 Ophthalmic ZSH, or ZSH involvement of 
the   ophthalmic division of the trigeminal nerve, results from the reactivation of 
chickenpox and varicella zoster virus (VZV), which are dormant in the trigeminal 
ganglion. It causes various symptoms such as trigeminal neuralgia, headache, and 
malaise.2 Ophthalmic ZSH is characterized by spontaneous pain in the area of the first 
branch of the trigeminal nerve, which is considered to be an important – and the only 
  subjective – symptom.3 Its diagnosis is difficult as blisters do not develop and there 
is no clue to its diagnosis other than orbital pain.4 For this reason, although a reliable 
diagnosis is difficult, early diagnosis is important as ZSH has also been reported 
to cause severe uveitis,5,6 acute retinal necrosis syndrome,7,8 and   neuroparalysis9 if 
left untreated.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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So far, elevated anti-VZV antibody titers have been 
reported as a useful finding for the diagnosis of ophthalmic 
herpes zoster;10 however, there are no reports concerning 
ophthalmic ZSH.
Herpes zoster is particularly common among patients with 
lymphoproliferative malignancies.11 In 1980, Miller found 
that lymphocyte proliferation to varicella-zoster antigen 
was lower in older asymptomatic individuals than in normal 
young controls.12 The precise roles of humoral and cellular 
immunity in protection against herpes zoster virus infection 
are controversial. However, cell-mediated immunity seems 
to be more important than humoral immunity, probably due 
to the spread of virus within the body which is exclusively 
via the intracellular route.
We considered that the lymphocyte count may trigger 
of onset process of ophthalmic ZSH, so our purpose in this 
study was to examine the significance of the determination of 
enzyme immunoassay (EIA), VZV-IgG (immunoglobulin G) 
levels (IgG), and peripheral blood lymphocyte counts (lym-
phocyte count) in the early diagnosis of ophthalmic ZSH.
Method
Only people who provided informed consent were eligible 
to participate in this study. Those involved were patients 
who visited the Marumoto Eye Clinic (Yokahama) between 
August 2008 and February 2009. Our study design   features 
a clinical case-control study. There were 65 patients with 
ophthalmic ZSH (16 males and 49 females; mean age 
56.3 ± 18.4 years) in whom pressure elicited pain in   tender 
points of Valleix13 (tender points of sites at which the 
trigeminal nerve appears subcutaneously). By pushing the 
patient’s upper eyelid with a forefinger over the eyeball, 
it becomes easier to elicit the pain of the tender points. 
Ophthalmic ZSH was suspected upon medical   examination 
by the interviewers, and for treatment internal use of 
  valacyclovir alone was administered and therapeutic diag-
nosis was   performed. For discriminating from episcleritis 
or scleritis, all cases had been prescribed only valacyclovir 
and no   topical steroids. Controls comprised 41 participants 
(17 males and 24 females, mean age 48.2 ± 20.9 years) in 
whom pressure did not elicit pain in tender points of   Valleix. 
Controls had visited the clinic during the same period as 
patients and received reports of cataract and refractive error. 
Controls were free from VZV disease and we gained consent 
to carry out the study with all participants. In each group, 
IgG and lymphocyte count were determined (outside ordered 
to Health Sciences Research Institute) upon   receiving the 
consent of the patients.
Pearson’s Chi-square tests and Mann-Whitney tests were 
conducted to explore the differences between participants 
with ophthalmic ZSH and the control group in terms of age, 
sex, IgG levels, and lymphocyte count. Multiple logistic 
regression analysis was used to evaluate the factors associate 
with the diagnosis of ophthalmic ZSH. First, all variables of 
age, gender, IgG levels, and lymphocyte count were analyzed 
in a univariate model. Then all variables were included in a 
multivariate model. Statistical significance was considered 
when P , 0.05 was reached. The role of each variable is 
expressed in odds ratio (OR) and the related 95% confidence 
intervals (CI). Computerized analysis was performed using 
STATA software version 8 (Statacorp., College Station, 
Texas, US).
Results
A total of 65 patients with ophthalmic ZSH and 41 controls 
were enrolled in the present study. Table 1 presents the 
symptoms and conditions of ophthalmic ZSH cases. In the 
ophthalmic ZSH group, in which participants experienced 
tenderness, 100% of the patients had an injection in the eye 
and almost 60% of the patients experienced lacrimation, 
headaches, and a stiff neck. After a course of valacyclovir, 
in all cases spontaneous pain and pain felt upon exerting 
pressure disappeared within 1 week, improving the   subjective 
symptoms of the patients.
Cases (N = 65) Symptoms
no. of patients (%)
Tenderness 100 (65)
Orbital pain  32 (21)
Injection 100 (65)
48 (31) Sandy sensation in eyes
Lacrimation 63 (41)
Dry eye 37 (24)
Headache 58 (38)
Stiff neck 62 (40)
Lassitude 49 (32)
Dizziness 32 (21)
Conditions no. of patients (%)
Overwork 75 (49)
Stress  60 (39)
The common cold 58 (38)
Lack of sleep 68 (44)
Irregular hours 23 (15)
History of VZV 32 (21)
Number of recurrence 23 (15)
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Details regarding age, gender, IgG, and lymphocyte 
count of the patients with ophthalmic ZSH and the control 
group are shown in Table 2. In both groups there were 
no significant differences in age, gender, and IgG. On 
the other hand, mean lymphocyte count was 1,765 ± 550 
and 2,276 ± 715 lymphocytes/µl in the patients with 
  ophthalmic ZSH and the control group, respectively, and 
was thus   significantly lower in patients with ophthalmic ZSH 
(P = 0.0003, Mann-Whitney test).
Furthermore, multiple logistic regression analysis using 
the absence of ophthalmic ZSH as dependent variable, and 
age, gender, IgG levels, and lymphocyte count as prognostic 
factors, was performed. Prognostic factors were classified 
as follows, age: per 1 year of age, gender: male/female, 
IgG levels: less than 16 and 16 or more, lymphocyte count: 
less than 1,800 lymphocytes/µl and 1,800 lymphocytes/µl 
or more. As a result of univariate analysis, age (OR, 1.02; 
95% CI, 1.00–1.04) and lymphocyte count (OR, 0.28; 
95% CI, 0.12–0.66) were found to be significant prognostic 
  factors. Multivariate analysis adjusted for age, gender, and 
IgG   levels revealed that only lymphocyte count was a signifi-
cant prognostic factor, and in the case of 1,800 lymphocytes/
µl and more, OR of less than 1,800 lymphocytes/µl was 0.29 
(95% CI, 0.12–0.72; Table 3).
Discussion
Ophthalmic ZSH was first described by Ross in 1949.14 In 
1958 Lewis reported 13 cases of ZSH among 120 cases of 
herpes zoster.3 VZV is dormant in the trigeminal ganglion of 
almost 100% of the Japanese population and is reactivated 
along with a decrease in the resistance power of the body, 
therefore causing the development of trigeminal neuralgia 
and shingles in the trigeminal nerve area.15 Although   various 
symptoms are produced as a result of the reactivation of 
this VZV , ophthalmic ZSH is a disease in which no shingles 
appear, and except for secondary trigeminal neuralgia caused 
by tumors of the trigeminal nerve, intracranial aneurysm, 
or paranasal sinus disease, pain is expected to completely 
disappear within weeks.16
It is speculated that the various symptoms found in the 
experimental group were produced as a result of reactivation 
of VZV . For example, a sandy sensation and lacrimation may 
be caused by hyperaesthesia of the trigeminal nerve, and 
these symptoms may be ignored as indefinite complaints. In 
this study, the ophthalmic ZSH group complained of general 
discomfort, such as headaches along the temples, stiff necks 
and shoulders, dizziness, and lassitude, which may have 
resulted from inflammation of the trigeminal nerve. These 
results suggested that the indefinite complaints may be able to 
be eliminated in response to antiviral therapy. In all cases, 
treatment involved internal use of valacyclovir alone and 
no steroids for topical or internal use were administered. 
Through systemic use of valacyclovir from an early stage at 
a low dose (daily dose of 1500 mg, 3 times a day for 5 days), 
in all cases spontaneous pain and pain felt upon exerting 
pressure disappeared within 1 week, improving the   subjective 
symptoms of the patients.
It is known that hemicrania is accompanied by 
allodynia,17 making patients feel a stinging pain from their 
hair and skin just by wind that is blowing against their fore-
head or around their eyes.18 Shimizu reported a 4.3 times 
higher rise in the development of allodynia for a group of 
hemicrania patients with high anti-VZV antibody titers 
compared to a group of hemicrania patients with low anti-
VZV antibody titers (cut-off value of 4 times or more for 
CF).19 Furthermore, these symptoms have been reported to 
improve through internal use of valacyclovir. These results 
suggest that VZV is involved in hemicrania accompanied by 
allodynia. In this study, together with allodynia, which pro-
duces spontaneous pain as subjective findings, we focused 
on tender points. At these sites, which are called tender 
points of Valleix, the trigeminal nerve appears subcutane-
ously. These sites are hypersensitive in case of trigeminal 
neuralgia and have been used for decades in the diagnosis 
of neuralgia.13 For the diagnosis of ophthalmic ZSH, the 
only pain that can be identified by hand diagnosis upon 
exerting pressure is considered significant for determining 
the hypersensitivity of the trigeminal nerve.13 The pain felt 
upon exerting pressure also is present when no spontaneous 
pain shows up and tender points could easily be identified. 
It has been speculated that although reactivated VZV does 
not cause a rash or headache, it lowers the pain threshold of 
trigeminal neurons, and thus causes excitability. All of the 
patients with ophthalmic ZSH felt pain in the tender points 
of both eyes upon exerting pressure; however, the pain in 
ZSH group
n = 65
(mean ± SD)
Control group
n = 41
(mean ± SD)
Age (years) 56.3 ± 18.4  48.2 ± 20.9 P = 0.0644* 
Gender (M/F Ratio)  16/49 (cases) 17/24 (cases) P = 0.0681**
VZV-IgG 19.8 ± 17.1  15.9 ± 11.3  P = 0.4023* 
Lymphocyte count 1,765 ± 550  2,276 ± 715  P = 0.0003* 
Table 2 Comparison of all prognostic factors
Notes: *Mann-Whitney test, **Chi-Square testClinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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one eye was stronger than in the other. Depending on the 
case, there were differences in the level of pain felt upon 
exerting pressure; in many cases the pain that was felt upon 
exerting pressure on the superior eyelid over the eyeball on 
the more painful side was so strong that the patient tried to 
move away. VZV-related disorders commonly occur in one 
eye; however, in case of ophthalmic ZSH the development 
of symptoms in both eyes has been reported.20 The reason 
why pain felt upon exerting pressure was confirmed for 
both eyes is not because the inflammation of the trigemi-
nal nerve of one eye spread to the other side, but because 
when the pain in the one eye is anterogradely passed on 
to the brain and the pain information is recognized, this 
information is   antidromically transmitted to the opposite 
trigeminal   ganglion.19 Furthermore, although the level of 
injection of conjunctiva was not necessarily reciprocated 
with the intensity of the pain felt upon exerting pressure, 
congestion characterized by overswelling of only a number 
of blood vessels of the bulbar conjunctiva of two cases 
was observed.
The virological investigation of VZV includes virus 
isolation, virus antigen (or DNA) detection, and the 
determination of specific antibody titers.14 As for the 
isolation of the virus, liquid from herpes blisters is used 
(although this method cannot be used for ophthalmic 
ZSH in which no rash develops).10 Additionally, for the 
detection of virus antigens, VZV-DNA in aqueous humor 
of the anterior eye chamber is quantitatively determined 
(real time PCR); however, this requires the collection of 
aqueous humor of the anterior eye chamber, and thus is 
unrealistic in general clinical practice.6 On the other hand, 
the determination of a VZV-specific serum antibody titer is 
done by taking blood samples. Methods used for the deter-
mination of specific antibody titers are complement-fixation 
reaction (CF), EIA, neutralization, fluorescent antibody test, 
and more. Currently, CF and EIA are often used in clinical 
practice. CF is superior with regard to simplicity and swift-
ness of the   examination method, and also has the advantage 
that it can be done at a moderate price (about one-third that 
of EIA).   However, both sensitivity and specificity are lower 
than in EIA21 and as often as cross-reactivity with the her-
pes simplex virus occurs, data must be handled with care.22 
Furthermore, for a reliable serological diagnosis, CF levels 
of paired serum (an interval of at least two weeks) from the 
acute and the recovery phase must be compared and a rise 
in two or more stages must be confirmed. It is difficult to 
compare pair serum in day-to-day ophthalmic practice and in 
fact this is not often done. On the other hand, by EIA, single 
sera can be diagnosed and it is said that VZV   infections can 
be detected if the assay is performed at least within 2 years 
after the onset of the infection, while in case of CF, sera are 
said to become diagnostically useless 6 months or more after 
onset of the infection.21 For these reasons, in the present study, 
we determined virus antibody titers by EIA. However, as a 
result no significant differences in IgG levels were observed 
between the patients with ophthalmic ZSH and the control 
group (Table 2). Furthermore, Yamakawa9 set the positive 
cut-off standard, which is defined as an   abnormally high IgG 
ZSH Univariate analysis Multivariate analysis
Odds ratio 95%
confidence 
interval
Odds ratio
(adjusted for
other factors)
95%
confidence 
interval
Age Per 1year 
of age
1.02 1.02 1.00–1.04 1.00–1.04
VZV-IgG <16 1 1
16≤  1.60 1.02 0.71–3.60 0.56–3.27
Gender Female 1 1
Male 0.43 0.47 0.29–1.07 0.17–1.06
Lymphocyte count <1,800 1 1
0.28 0.29 0.12–0.66 0.12–0.72 1,800≤
Table 3 Logistic regression analysisClinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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value at an EIA value of 50; however, in our study, only in 4 of 
the 65 participants of the patients with ophthalmic ZSH was 
an IgG of 50 or more observed, while the mean value was 18. 
This result let us assume that the IgG value provides no helpful 
information for the early diagnosis of ophthalmic ZSH. The 
reason is that in the case of ophthalmic ZSH no rash develops, 
and ophthalmic ZSH is believed to be an inflammation that 
is confined to the trigeminal and occipital nerve. In the stage 
of the early diagnosis of ophthalmic ZSH through identifying 
pain that is felt upon exerting pressure, no anti-VZV antibody, 
including immunoglobulin (humoural immunity), has yet 
elicited a strong response. On the other hand, high IgG levels 
(maximum value 45.9) were also observed in the healthy 
control cases. Generally, IgG is said to show the history of all 
VZV reactivations during the last 2 years,22 and thus do not 
necessarily capture the present VZV-reactivation state.
Regarding lymphocyte counts, univariate analysis also 
revealed significant differences between the two groups. 
Furthermore, as a result of multivariate analysis in which 
the patients with ophthalmic ZSH were separated into two 
groups with the medium value of the normal lymphocyte 
count of 1,800 lymphocytes/µl as limit, it was revealed 
that lymphocyte counts had a relevance three times higher 
in the less than 1,800 lymphocytes/µl group, compared to 
the 1,800 lymphocytes/µl or more group. Upon medical 
examination by the interviewers of all of the patients with 
ophthalmic ZSH, one or more of the following complaints 
were reported: stress, lack of sleep, coldness in one’s hands 
and feet, or irregular lifestyle. In a state in which the sym-
pathetic nerves are superior as described above, lymphocyte 
counts in serum decrease. This is because an increase in the 
lymphocyte count in serum is controlled by the parasympa-
thetic nerves and in a state in which the sympathetic nerves 
are superior, the lymphocyte count decreases.23,24 There is a 
possibility that a decrease in the lymphocyte count triggered 
VZV reactivation and the onset of ophthalmic ZSH.
In conclusion, we believe that patients with orbital pain 
should be tested for the presence of ophthalmic ZSH, and 
that it is useful to determine lymphocyte counts after tender 
points are confirmed. The swift diagnosis of ophthalmic 
ZSH and the administration of antiviral drugs from an 
early stage improve the subjective symptoms of the patient 
and is regarded necessary to reduce the risk of severe 
complications.
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